Sichenzia Ross Ference LLP Represents Spartan Capital Securities, LLC in $6.25 Million Registered Direct Offering of Common Stock of Processa Pharmaceuticals, Inc.
Press Release – New York, New York – February 15, 2023 – Sichenzia Ross Ference LLP announced today that it represented Spartan Capital Securities, LLC in a registered direct offering of common stock of Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) (the “Company”), a diversified clinical-stage company developing next generation chemotherapy drugs. The Company has entered into definitive agreements with investors for the purchase and sale of 7,812,544 common shares at a purchase price of $0.80 per share priced at-the-market under NASDAQ rules. The gross proceeds from the registered direct offering were $6.25 million.
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia and Avital Perlman, associate Kayla Scoccola, and law clerk Anastasia Hayes.